Effective inhibition of cancer cells by recombinant adenovirus expressing EGFR-targeting artificial microRNA and reversed-caspase-3
Author:
Funder
National Natural Science Foundation of China
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference26 articles.
1. The quest to overcome resistance to EGFR-targeted therapies in cancer;CR Chong;Nat Med,2013
2. Emerging functions of the EGFR in cancer;S Sigismund;Mol Oncol,2018
3. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors;LV Sequist;Sci Transl Med,2011
4. Osimertinib or platinum–pemetrexed in EGFR T790M–positive lung cancer;TS Mok;N Engl J Med,2017
5. Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers;AY Helena;Clin Cancer Res,2013
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Challenges and Opportunities of Gene Therapy in Cancer;OBM Genetics;2024-03-04
2. Construction and application of adenoviral vectors;Molecular Therapy - Nucleic Acids;2023-12
3. Application of mPEG-CS-cRGD/ Bmi-1RNAi -PTX nanoparticles in suppression of laryngeal cancer by targeting cancer stem cells;Drug Delivery;2023-02-21
4. Applications of tissue-specific and cancer-selective gene promoters for cancer diagnosis and therapy;Advances in Cancer Research;2023
5. Strategies to Improve the Targeting of Retinal Cells by Non-Viral Gene Therapy Vectors;Frontiers in Drug Delivery;2022-05-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3